The European Association for Vision and Eye Research (EVER) is the leading ophthalmological research association in Europe, which covers all areas of ophthalmology and the visual sciences. One of the main activities of EVER is the organizing of a high quality research meeting every year at a location chosen for its access and congress facilities. EVER collaborates closely with other societies in organizing joint meetings during EVER.
touchOPHTHALMOLOGY caught up with the President of EVER, Manuel Vidal Sanz, to discuss the objectives of the Association in 2022 and its research priorities.
For more information, please visit: https://www.everassociation.org/
- What are the objectives of EVER? (00:17)
- What are the major challenges faced by the ophthalmology community at the moment? (02:04)
- What are EVER’s research priorities for the coming year? (04:08)
Disclosures: Manuel Vidal Sanz has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Lisa Glass.
Share this Video
Related Videos In Refractive Surgery
Mitchell A Jackson, Hawaiian Eye and Retina 2023: Intraocular lens exchange – surgical pearls
It was a pleasure to have the opportunity to meet with Dr Mitchell A Jackson (Jacksoneye, Lake Villa, IL, USA) who shared surgical pearls from his presentation, on successful IOL exchange with an open capsule. Questions: What risks are associated with intraocular lens (IOL) exchange with an open capsule? (0:19) What […]
Mitchell A Jackson, Hawaiian Eye and Retina 2023: Challenges for ophthalmic surgeons
We were delighted to speak with Dr Mitchell A Jackson (Jacksoneye, Lake Villa, IL, USA) on his views about the main challenges faced by ophthalmic surgeons today, and common reasons for IOL exchange. Questions: 1. What are the biggest challenges facing ophthalmologic surgeons today? (0:19) 2. What are the most common reasons for intraocular lens […]
Pilocarpine hydrochloride ophthalmic solution 1.25%: An innovative prescription eye drop for the treatment of presbyopia
Video abstract delivered by Dr Selina McGee (BeSpoke Vision, Edmond, OK, USA) for the article: McGee S, Waring GO, Pilocarpine hydrochloride ophthalmic solution 1.25%: an innovative prescription eye drop for the treatment of presbyopia. touchREVIEWS in Ophthalmology. 2022;16(2):54–62 DOI: https://doi.org/10.17925
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!